外耳炎

Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 Suppl):S1-S24.全文  摘要

Hirsch BE. Infections of the external ear. Am J Otolaryngol. 1992 May-Jun;13(3):145-55. 摘要

Selesnick SH. Otitis externa: management of the recalcitrant case. Am J Otology. 1994 May;15(3):408-12. 摘要

Mösges R, Nematian-Samani M, Hellmich M, et al. A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa. Curr Med Res Opin. 2011 Oct;27(10):2053-60. 摘要

1. Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 Suppl):S1-S24.全文  摘要

2. Browning GG. Aetiopathology of inflammatory conditions of the external and middle ear. In: Kerr AG, ed. Scott-Brown's Otolaryngology. Oxford, UK: Butterworth-Heinemann; 1997.

3. Hirsch BE. Infections of the external ear. Am J Otolaryngol. 1992 May-Jun;13(3):145-55. 摘要

4. Lee SK, Lee SA, Seon SW, et al. Analysis of prognostic factors in malignant external otitis. Clin Exp Otorhinolaryngol. 2017 Sep;10(3):228-35.全文  摘要

5. Walshe P, Cleary M, McConn WR, et al. Malignant otitis externa: a high index of suspicion is still needed for diagnosis. Irish Med J. 2002 Jan;95(1):14-6. 摘要

6. Johnson AK, Batra PS. Central skull base osteomyelitis: an emerging clinical entity. Laryngoscope. 2014 May;124(5):1083-7. 摘要

7. Schaefer P, Baugh RF. Acute otitis externa: an update. Am Fam Physician. 2012 Dec 1;86(11):1055-61.全文  摘要

8. Selesnick SH. Otitis externa: management of the recalcitrant case. Am J Otology. 1994 May;15(3):408-12. 摘要

9. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope. 2002 Jul;112(7 Pt 1):1166-77. 摘要

10. Rowlands S, Devalia H, Smith C, et al. Otitis externa in UK general practice: a survey using the UK General Practice Research Database. Br J Gen Pract. 2001 Jul;51(468):533-8.全文  摘要

11. Livingstone DM, Smith KA, Lange B. Scuba diving and otology: a systematic review with recommendations on diagnosis, treatment and post-operative care. Diving Hyperb Med. 2017 Jun;47(2):97-109. 摘要

12. Schwartz SR, Magit AE, Rosenfeld RM, et al. Clinical practice guideline (update): earwax (cerumen impaction). Otolaryngol Head Neck Surg. 2017 Jan;156(1_suppl):S1-29.全文  摘要

13. Chan KL, Soo G, van Hasselt CA. Furunculosis. Ear Nose Throat J. 1997;76:126. 摘要

14. Dubach P, Mantokoudis G, Caversaccio M. Ear canal cholesteatoma: meta-analysis of clinical characteristics with update on classification, staging and treatment. Curr Opin Otolaryngol Head Neck Surg. 2010 Oct;18(5):369-76. 摘要

15. Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest. 2004 Mar;113(5):651-7.全文  摘要

16. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015 Feb 1;91(3):185-90.全文  摘要

17. Dimitroulis G. Temporomandibular disorders: a clinical update. BMJ. 1998 Jul 18;317(7152):190-4.全文  摘要

18. Kaushik V, Malik T, Saeed SR. Interventions for acute otitis externa. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004740. 摘要

19. Kantas I, Balatsouras DG, Vafiadis M, et al. The use of trichloroacetic acid in the treatment of acute external otitis. Eur Arch Otorhinolaryngol. 2007 Jan;264(1):9-14. 摘要

20. Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J. 2003 Apr;22(4):299-305; quiz 306-8. 摘要

21. van Balen FA, Smit WM, Zuithoff NP, et al. Clinical efficacy of three common treatments in acute otitis externa in primary care: randomised controlled trial. BMJ. 2003 Nov 22;327(7425):1201-5.全文  摘要

22. Lambert IJ. A comparison of the treatment of otitis externa with "Otosporin" and aluminium acetate: a report from a services practice in Cyprus. J R Coll Gen Pract. 1981 May;31(226):291-4.全文  摘要

23. Mösges R, Schröder T, Baues CM, et al. Dexamethasone phosphate in antibiotic ear drops for the treatment of acute bacterial otitis externa. Curr Med Res Opin. 2008 Aug;24(8):2339-47. 摘要

24. Pistorius B, Westberry K, Drehobl M, et al. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externa. Infect Dis Clin Pract. 1999;8:387-95.

25. Jones RN, Milazzo J, Seidlin M. Ofloxacin otic solution for treatment of otitis externa in children and adults. Arch Otolaryngol Head Neck Surg. 1997 Nov;123(11):1193-200. 摘要

26. Wall GM, Stroman DW, Roland PS, et al. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. Pediatr Infect Dis J. 2009 Feb;28(2):141-4. 摘要

27. Mösges R, Nematian-Samani M, Hellmich M, et al. A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa. Curr Med Res Opin. 2011 Oct;27(10):2053-60. 摘要

28. Wang X, Winterstein AG, Alrwisan A, et al. Risk for tympanic membrane perforation after quinolone ear drops for acute otitis externa. Clin Infect Dis. 2019 May 2. pii: ciz345. 摘要

29. Rahman A, Rizwan S, Waycaster C, et al. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children. Clin Ther. 2007 Sep;29(9):1950-6. 摘要

30. Roland PS, Belcher BP, Bettis R, et al; Cipro HC Study Group. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa. Am J Otolaryngol. 2008 Jul-Aug;29(4):255-61. 摘要

31. Hannley MT, Denneny JC 3rd, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. 2000 Jun;122(6):934-40. 摘要

32. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. November 2018 [internet publication].全文

33. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. March 2019 [internet publication].全文

34. US Food & Drug Administraton. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. May 2016 [internet publication].全文

35. US Food and Drug Administration. FDA drug safety communication. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. December 2018 [internet publication].全文

36. US Food and Drug Administration. FDA drug safety communication. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. July 2018 [internet publication].全文

37. Hopkins ME, Bennett A, Henderson N, et al. A retrospective review and multi-specialty, evidence-based guideline for the management of necrotising otitis externa. J Laryngol Otol. 2020 Jun;134(6):487-92.全文  摘要

38. Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am. 2008 Jun;41(3):537-49, viii-ix. 摘要

39. Bernstein JM, Holland NJ, Porter GC, et al. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa. J Laryngol Otol. 2007 Feb;121(2):118-23. 摘要

40. Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg. 2003 Oct;11(5):316-23. 摘要

41. Franco-Vidal V, Blanchet H, Bebear C, et al. Necrotizing external otitis: a report of 46 cases. Otol Neurotol. 2007 Sep;28(6):771-3. 摘要

42. Amaro CE, Espiney R, Radu L, et al. Malignant (necrotizing) externa otitis: the experience of a single hyperbaric centre. Eur Arch Otorhinolaryngol. 2019 Jul;276(7):1881-87.全文  摘要

43. Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev. 2013 May 31;(5):CD004617.全文  摘要

44. Martin TJ, Kerschner JE, Flanary VA. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol. 2005 Nov;69(11):1503-8. 摘要

45. Mion M, Bovo R, Marchese-Ragona R, et al. Outcome predictors of treatment effectiveness for fungal malignant external otitis: a systematic review. Acta Otorhinolaryngol Ital. 2015 Oct;35(5):307-13.全文  摘要

46. Demir D, Yılmaz MS, Güven M, et al. Comparison of clinical outcomes of three different packing materials in the treatment of severe acute otitis externa. J Laryngol Otol. 2018 Jun 13;132(6):523-28. 摘要

47. US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. April 2017 [internet publication].全文

48. Medicines and Healthcare Products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. December 2014 [internet publication].全文

49. European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication].全文

50. Ali T, Meade K, Anari S, et al. Malignant otitis externa: case series. J Laryngol Otol. 2010 Aug;124(8):846-51. 摘要